Monika Chapman, NP
Women's Health · Wilmington, DENPI 1588332670
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations.
Across 58 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$153
- Sage Therapeutics, LLC$133
- Myovant Sciences Inc.$104
- Exeltis, USA Inc.$95
- Shield Therapeutics Inc$81
- Mayne Pharma Commercial LLC$72
- plus $470 from 12 others
What the payments were for
- Food & beverage$1,107100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $153 |
| Sage Therapeutics, LLC | 6 | $133 |
| Myovant Sciences Inc. | 5 | $104 |
| Exeltis, USA Inc. | 5 | $95 |
| Shield Therapeutics Inc | 2 | $81 |
| Mayne Pharma Commercial LLC | 8 | $72 |
| Pfizer | 3 | $60 |
| AbbVie | 3 | $54 |
| Astellas Pharma US Inc | 2 | $54 |
| Evofem Biosciences, Inc. | 4 | $53 |
| Novo Nordisk | 3 | $48 |
| Bayer | 2 | $45 |
| Hologic Sales And Service, LLC | 2 | $42 |
| Organon | 1 | $28 |
| Exact Sciences | 1 | $25 |
| Coopersurgical, Inc. | 1 | $22 |
| Millicent US Inc | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
How this compares
$1,107 in reported general payments places this provider in the 75th percentile of 29 women's health providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 35 | $2,229 |
| Metronidazole | 13 | $202 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $144 |
| Alendronate Sodium | 21 | $138 |
| Fluconazole | 19 | $58 |
Paid to pharmacies, not to this prescriber.
Other women's health in Wilmington
- Emmanuella OlaiyaWilmington$2K
- Emily SmithWilmington$2K
- Monica MaldonadoWilmington$227
- Ludora RiegelWilmington$160
- Brittany WoltemateWilmington$29
- Nancy Baron-WelchNewark$4K
- Theresa InerfieldClaymont$3K
- Teresa HarrisDover$3K
- Kimberly Ross-TilleyDover$2K
- Nadine HenryMilford$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.